Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
SELECT trial
Description:
The SELECT trial was a randomized clinical trial evaluating whether selenium and vitamin E supplementation could prevent prostate cancer in men.
Related topics:
Diabetes Treatment and Management (20%),
Selenium in Biological Systems (13%),
Thyroid Cancer Diagnosis and Treatment (11%)
OpenAlex ID:
keywords/select-trial
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023
·
A. Michael Lincoff
, Kirstine Brown-Frandsen
, et al.
·
New England Journal of Medicine
·
3,863
PDF
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers
2008
·
Scott M. Lippman
, Eric A. Klein
, et al.
·
JAMA
·
2,371
PDF
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
2024
·
Donna H. Ryan
, Ildiko Lingvay
, et al.
·
Nature Medicine
·
467
PDF
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
2024
·
Sunil V Badve
, Anika Bilal
, et al.
·
The Lancet Diabetes & Endocrinology
·
435
PDF
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
2005
·
Scott M. Lippman
, Phyllis J. Goodman
, et al.
·
JNCI Journal of the National Cancer Institute
·
378
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
2024
·
John Deanfield
, Subodh Verma
, et al.
·
The Lancet
·
357
Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer’s Disease by Vitamin E and Selenium Trial (PREADViSE)
2017
·
Richard J. Kryscio
, Erin L. Abner
, et al.
·
JAMA Neurology
·
322
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
2020
·
Donna H. Ryan
, Ildiko Lingvay
, et al.
·
American Heart Journal
·
295
PDF
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
2024
·
Helen M. Colhoun
, Ildiko Lingvay
, et al.
·
Nature Medicine
·
289
Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds
2004
·
R. Sinha
, K. El-Bayoumy
·
Current Cancer Drug Targets
·
273
Select: the Next Prostate Cancer Prevention Trial
2001
·
ERIC A. KLEIN
, IAN M. THOMPSON
, et al.
·
The Journal of Urology
·
264
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme
2020
·
Stanley B Cohen
, Ronald F van Vollenhoven
, et al.
·
Annals of the Rheumatic Diseases
·
252
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX- inhibiting Therapies (SELECT) trial in osteoarthritis
1998
·
J. Dequeker
, C. Hawkey
, et al.
·
Rheumatology
·
247
Selenium supplementation for the primary prevention of cardiovascular disease
2013
·
Karen Rees
, Louise Hartley
, et al.
·
Cochrane Database of Systematic Reviews
·
220
PDF
Selenoproteins and human health: Insights from epidemiological data
2009
·
Margaret P. Rayman
·
Biochimica et Biophysica Acta (BBA) - General Subjects
·
216
SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
2018
·
Nathan A. Pennell
, Joel W. Neal
, et al.
·
Journal of Clinical Oncology
·
215
Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial
2017
·
Marcia S. Brose
, Francis P. Worden
, et al.
·
Journal of Clinical Oncology
·
209
Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study
2019
·
Amrou Sarraj
, Ameer E. Hassan
, et al.
·
JAMA Neurology
·
205
PDF
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
2025
·
John Deanfield
, A Michael Lincoff
, et al.
·
The Lancet
·
189
PDF
SELECT: the selenium and vitamin E cancer prevention trial
2003
·
Eric A Klein
, Ian M Thompson
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
159
Selenium as a Bioactive Micronutrient in the Human Diet and Its Cancer Chemopreventive Activity
2021
·
Dominika Radomska
, Robert Czarnomysy
, et al.
·
Nutrients
·
150
PDF
Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics
2013
·
A Paschos
, R Pandya
, et al.
·
Prostate Cancer and Prostatic Diseases
·
147
Selenium for preventing cancer
2011
·
Gabriele Dennert
, Marcel Zwahlen
, et al.
·
Cochrane Database of Systematic Reviews
·
147
PDF
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
2022
·
Ildiko Lingvay
, Kirstine Brown‐Frandsen
, et al.
·
Obesity
·
141
Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer
2015
·
Naomi Kiyota
, Martin Schlumberger
, et al.
·
Cancer Science
·
141
PDF
Show more works
View as search
Works count:
616
Citation count:
17,130
Year
Topic
Type